LRRK2 and Parkinson disease: Although there is some variability in experimental results across the LRRK2 literature, most studies suggest that Parkinson’s disease-promoting mutations in the GTPase domain decrease the GTPase activity of LRRK2 and increase the proportion of GTP-bound LRRK2 [73].